Please login or register first to view this content.
News
NEWS
Latest News
Intensive BP-lowering Treatment May Reduce the Risk for Orthostatic Hypotension
Aspirin May Be Considered for Primary Prevention of CVD in Rheumatic Diseases
Early Rhythm Control Therapy for Newly Diagnosed Atrial Fibrillation
Self-Expanding Intra-Annular Transcatheter Aortic Valve vs Commercially Available Systems
AHA Issues Statement on Drug-Induced Arrhythmias
FDA to Review Avacopan for ANCA-Associated Vasculitis
Coronary Artery Calcium Score May Help Predict Coronary Heart Disease Risk
Mavacamten Treatment for Obstructive Hypertrophic Cardiomyopathy
Empagliflozin Beneficial in Heart Failure With Reduced Ejection Fraction
Drug News from MPR
BP Dipping May Be a Marker of CV Function in Pediatric-Onset SLE
FDA Issues Emergency Use Authorization for Point-of-Care COVID-19 Tests
Ozempic Approved to Reduce Risk of Major Adverse Cardiovascular Events
Provider Gaps Identified in Cardiopulmonary Care
Rilonacept Gets Breakthrough Therapy Status for Recurrent Pericarditis
Cardiometabolic Effects of Gender-Affirming Hormone Therapy in Transgender Youth
Oral Suspension Formulation of Amlodipine Now Available
How I Treat My Patients With Sacubitril/Valsartan for Heart Failure With Reduced Ejection Fraction
Rivaroxaban Appears Safe, Effective for Pediatric Acute VTE
Inclisiran Associated With Sustained LDL-C Reduction in ORION-3 Study
-
Loading...
-
Loading...
Want to read more?
Next post in News
